Skip to content
Glossary · Treatments

JAK inhibitors

Also called Janus kinase inhibitors, baricitinib, ritlecitinib, deuruxolitinib

In one line

Pills that calm an overactive immune system. Three are FDA-approved for severe alopecia areata: baricitinib, ritlecitinib and deuruxolitinib.

What jak inhibitors means for your hair

JAK inhibitors are medicines that block Janus kinase enzymes, part of the signaling the immune system uses to drive inflammation. In alopecia areata, where the immune system attacks hair follicles, calming that signaling can let hair regrow. The AAD reports that the FDA has approved three JAK inhibitors for alopecia areata: baricitinib, a once-daily pill for people 12 and older with severe disease; ritlecitinib, a once-daily pill for people 12 and older with extensive hair loss; and deuruxolitinib, a twice-daily pill for adults with severe disease.

Many studies show 50 percent or greater regrowth for some patients, including eyebrows and eyelashes. They are prescription medicines with possible serious side effects, so they require screening and monitoring by a dermatologist. They are not approved for pattern hair loss.

Plain-English definitions for education, not medical advice. Only a clinician who examines you can tell you the cause of hair loss or which treatment suits you.